• Augmenter la taille
  • Taille par défaut
  • Diminuer la taille

Fiche personnelle de

Envoyer Imprimer PDF


Mohamed. Majdoub
U.B.O.

M. Mohamed MAJDOUB

COORDONNEES

LaTIM

  • LaTIM
  • Bâtiment 2bis (I3S)
    CHU Morvan - 5, Av. Foch
  • 29609 Brest CEDEX

U.B.O.

  • U.B.O.
  • 3 rue des Archives
    CS 93837
  • 29238 Brest cedex 3

CV COURT

Mohamed MAJDOUB est doctorant sous la direction de Mathieu HATT et l’encadrement de Dimitris Visvikis.


Après l’obtention d’un master 2  ingénierie biomédicale à l’université Henri Poincaré de Nancy en 2011, il entame des travaux de thèse portant sur « les modèles prédictifs et classification multi variées en analyse d’images multi modales pour la radiothérapie ».



Publications

Tooltip>= | CHERCHER | PREMIER_AUTEUR
2015  D. Groheux, A. Sanna, Majdoub M, P. de Cremoux, S. Giacchetti, L. Teixeira, M. Espié, P. Merlet, A. de Roquancourt, Visvikis D, Hatt M, Elif Hindié:Baseline tumor 18FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2- breast cancer.. Journal of Nuclear Medicine, 2015,,0-0,O,M,GB
  D. Groheux, Majdoub M, Tixier F, Cheze-Le Rest C, A. Martineau, P. Merlet, M. Espié, A. de Roquancourt, E. Hindié, Hatt M, Visvikis D:Do clinical, histological or immunohistochemical primary tumor characteristics translate into different 18FDG-PET/CT volumetric and heterogeneity features in stage II-III breast cancer?.. European Journal of Nuclear Medicine and Molecular Imaging, 2015,,0-0,O,M,GB
  D. Groheux, Majdoub M, A. Martineau, Visvikis D, M. Espié, Hatt M, E. Hindié:Early metabolic response to neoadjuvant treatment: 18FDG-PET/CT criteria according to breast cancer subtype.. Radiology, 2015,,0-0,O,M,GB
  Hatt M, Majdoub M, M. Vallières, Tixier F, Cheze-Le Rest C, D. Groheux, E. Hindié, A. Martinea, Pradier O, R. Hustinx, I. El Naqa, D. Visvikis:FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.. Journal of Nuclear Medicine, 2015,56(1),38-44,O,M,GB
2014  Hatt M, Tixier F, Majdoub M, Cheze-Le Rest C, Pradier O, R. Hustinx, Visvikis D:Quantification of intra-tumor 18F-FDG PET tracer uptake heterogeneity through textural features analysis: which minimum functional tumor volume to consider.. Society of nuclear medicine and molecular imaging annual meeting, 2014,,0-0,A,A,GB
2013  Hatt M, Tixier F, Hanzouli H, Majdoub M, Cheze-Le Rest C, Visvikis D:PET image analysis for response to therapy prediction in oncology.. European Molecular Imaging Meeting, 2013,,0-0,A,A,GB
  Majdoub M, Visvikis D, Tixier F, B. Hoeben, E. Visser, Cheze-Le Rest C, Hatt M:Proliferative 18F-FLT PET tumor volumes characterization for prediction of locoregional recurrence and disease-free survival in head and neck cancer.. Society of nuclear medicine and molecular imaging annual meeting, 2013,,0-0,A,A,GB
2011  Majdoub M, Graff P, Herlevin K, Diaz J-C, Noël A, Kafrouni H, Peiffert D, Wolf D:Analyse statistique de la délinéation des organes à risque pour les traitements de la sphère ORL en radiothérapie conformationnelle .. Cancer Radiothérapie, 2011,15, numéro 6-7,582-583,C,M,FR